z-logo
Premium
Adaptability of the semi‐invariant natural killer T‐cell receptor towards structurally diverse CD1d‐restricted ligands
Author(s) -
Florence William C,
Xia Chengfeng,
Gordy Laura E,
Chen Wenlan,
Zhang Yalong,
ScottBrowne James,
Kinjo Yuki,
Yu Karl O A,
Keshipeddy Santosh,
Pellicci Daniel G,
Patel Onisha,
KjerNielsen Lars,
McCluskey James,
Godfrey Dale I,
Rossjohn Jamie,
Richardson Stewart K,
Porcelli Steven A,
Howell Amy R,
Hayakawa Kyoko,
Gapin Laurent,
Zajonc Dirk M,
Wang Peng George,
Joyce Sebastian
Publication year - 2009
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/emboj.2009.286
Subject(s) - biology , adaptability , cd1d , receptor , computational biology , microbiology and biotechnology , genetics , natural killer t cell , immune system , ecology , t cell
The semi‐invariant natural killer (NK) T‐cell receptor (NKTcr) recognises structurally diverse glycolipid antigens presented by the monomorphic CD1d molecule. While the α‐chain of the NKTcr is invariant, the β‐chain is more diverse, but how this diversity enables the NKTcr to recognise diverse antigens, such as an α‐linked monosaccharide (α‐galactosylceramide and α‐galactosyldiacylglycerol) and the β‐linked trisaccharide (isoglobotriaosylceramide), is unclear. We demonstrate here that NKTcrs, which varied in their β‐chain usage, recognised diverse glycolipid antigens with a similar binding mode on CD1d. Nevertheless, the NKTcrs recognised distinct epitopic sites within these antigens, including α‐galactosylceramide, the structurally similar α‐galactosyldiacylglycerol and the very distinct isoglobotriaosylceramide. We also show that the relative roles of the CDR loops within the NKTcr β‐chain varied as a function of the antigen. Thus, while NKTcrs characteristically use a conserved docking mode, the NKTcr β‐chain allows these cells to recognise unique aspects of structurally diverse CD1d‐restricted ligands.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here